Banedanmark Awards DKK 80 Million Railway Track Component Framework to Dena Stahlbau
18 Aug 2026
Banedanmark has awarded a DKK 80 million framework agreement for milled rail inserts to Dena Stahlbau GmbH & Co. KG. The four-year framework covers the supply of railway track components and accessories for Denmark's rail infrastructure network, with options for two two-year extensions. Introduction Railway infrastructure requires specialised components to ensure safe and reliable train operations. Banedanmark, the Danish railway infrastructure manager, has established a framework for the supply of milled rail inserts (Fræsede Indpassere)—specialised components used in track construction and maintenance. The framework, valued at up to DKK 80 million (approximately €10.7 million), has been awarded to Dena Stahlbau GmbH & Co. KG, a German steel construction company. The contract runs for four years, with options for two two-year extensions. This procurement ensures that Banedanmark has access to high-quality railway track components for maintaining and developing Denmark's rail network. Why This Contract Matters Railway track components are essential for maintaining safe and efficient train operations. This framework ensures the supply of specialised milled rail inserts for Denmark's rail infrastructure. This contract matters because it: Supports rail infrastructure: Provides essential track components Ensures rail safety: High-quality components for track construction Significant value: DKK 80 million framework Long-term supply: 4 years + 2 x 2-year options German supplier: Dena Stahlbau is a German company Competitive process: Two bids received Price-focused: Price-only evaluation Contract Timeline Contract award notice published: 18 August 2026 (OJ S 158/2026) Previous notice referenced: 4dbe4668-9abe-4221-81f6-0bfd51ba604e-01 Winner chosen: 1-10 October 2024 Contract concluded: 31 October 2024 / 1 January 2025 Coverage start date: 1 November 2024 Coverage end date: 31 October 2028 (+ 2 x 2-year options) Contract Overview Banedanmark conducted an open procedure under the EU Sector Directive for this procurement. The framework covers the supply of milled rail inserts and related railway track components. Key features include: Single lot: Milled rail inserts and accessories Duration: 1 November 2024 – 31 October 2028 (4 years) Options: 2 x 2-year extensions (max 8 years) Value: Up to DKK 80,000,000 Evaluation: Price only Winner: Dena Stahlbau GmbH & Co. KG No subcontracting: Dena Stahlbau will deliver without subcontracting Key Contract Details Detail Information Contracting authority Banedanmark Winning bidder Dena Stahlbau GmbH & Co. KG Contract subject Milled rail inserts (CPV 34941000) Procedure type Open procedure Legal basis EU Directive 2014/25/EU Maximum value (DKK) DKK 80,000,000.00 Estimated value (DKK) DKK 60,000,000.00 Awarded value (DKK) DKK 31,965,687.00 Contract duration 4 years + 2 x 2-year options (max 8 years) Bids received 2 EU funding None Covered by GPA Yes Evaluation criteria Price only Subcontracting No Supplier location Germany Project Scope The framework covers the supply of milled rail inserts and related railway track components: Products Covered Milled rail inserts: Specialised milled components for track construction Railway track materials: Rails, crossovers, and accessories Track construction materials: Components for railway infrastructure Railway equipment: Associated railway equipment Contract Features Framework agreement: Without reopening of competition Duration: 4 years (1 November 2024 – 31 October 2028) Options: 2 x 2-year extensions (max 8 years) Performance: Delivery to Banedanmark's requirements About the Contracting Authority Banedanmark is the Danish railway infrastructure manager, responsible for operating, maintaining, and developing Denmark's rail network. The organisation ensures safe and efficient train operations across the country's railway system. About the Winning Company Dena Stahlbau GmbH & Co. KG is a medium-sized German steel construction company based in Osnabrück. The company specialises in steel construction, railway components, and milled rail inserts. Dena Stahlbau has expertise in manufacturing specialised railway track components for infrastructure projects. The company's winning bid of DKK 31,965,687 was the lowest of two tenders received. Procurement Analysis Procedure: An open procedure under the EU Sector Directive was used, applying to railway services. Competition: Two bids were received, representing a competitive field for a specialist railway component procurement. Evaluation criteria: Price only. The buyer selected the supplier based solely on price, with quality assured through technical specifications. Value for money: The winning bid (DKK 31.97 million) was below the highest bid (DKK 32.79 million), a saving of approximately 2.5%. German supplier: Dena Stahlbau is a German company, demonstrating cross-border supply in the European railway market. No subcontracting: Dena Stahlbau will deliver without subcontracting. Long-term framework: 4 years with 2 x 2-year options provides stability. Additional Procurement Facts The contract is covered by the WTO's Government Procurement Agreement (GPA). No EU funds were used for this procurement. The procurement was not accelerated. No dynamic purchasing system was used. Framework agreement without reopening of competition. Two bids were received. No subcontracting was declared. Disputes or review requests fall to Klagenævnet for Udbud. The winner is a German company. Market & Industry Perspective The European railway supply market is competitive, with specialised manufacturers across the continent. Railway track components require precision engineering and compliance with strict safety standards. Key trends in this market include: Specialist manufacturing: Railway components require precision engineering Cross-border supply: Suppliers from across Europe compete Safety standards: Strict compliance with railway safety regulations Infrastructure investment: Rail networks are being maintained and upgraded Price focus: Price is a key evaluation criterion Economic Significance At up to DKK 80 million, this framework represents a significant procurement for Denmark's rail infrastructure. The contract ensures: Supply security: Access to essential track components Infrastructure maintenance: Supports rail network upkeep Cross-border trade: Supports German supplier Cost efficiency: Competitive procurement delivers value for money Future Procurement Opportunities With the framework now in place, future opportunities include: Contract extensions: Up to 2 x 2-year options Re-tender: The framework will be re-tendered after 4-8 years Other railway components: Similar procurements for other track materials Other European infrastructure managers: Similar frameworks by other rail authorities Opportunities for Suppliers While this framework is awarded, future opportunities exist for railway component suppliers: Subcontracting: Suppliers may find subcontracting opportunities Other European infrastructure managers: Similar frameworks by other rail authorities Other railway components: Switches, crossings, and other track materials Re-tender: The framework will be re-tendered in the future What Businesses Should Watch Banedanmark's future procurement notices Other European railway infrastructure managers' tenders Changes to railway safety standards EU railway procurement regulations Infrastructure investment programmes DenmarkTenders Procurement Intelligence This railway component framework is a significant procurement for Banedanmark. Several features stand out: Scale: DKK 80 million over 4-8 years Price focus: Price-only evaluation Cross-border supply: German supplier winning Danish contract Specialist product: Milled rail inserts require specialist manufacturing Long-term framework: Up to 8 years with options For suppliers, this procurement highlights the importance of: Competitive pricing: Price is the sole criterion Product quality: Meeting technical specifications European presence: Ability to supply across borders Specialist expertise: Capability in railway component manufacturing Supplier Takeaways Offer competitive pricing—price is the sole criterion Ensure product quality meets technical specifications Develop European presence to supply cross-border Monitor other European rail infrastructure managers for similar opportunities Build specialist expertise in railway component manufacturing Key Takeaways Banedanmark awarded a DKK 80 million railway component framework to Dena Stahlbau Products: Milled rail inserts and railway track components Duration: 4 years + 2 x 2-year options (max 8 years) Evaluation: Price only 2 bids received German supplier (Dena Stahlbau) No subcontracting No EU funding used Conclusion This railway component framework represents a significant procurement for Denmark's rail infrastructure. By awarding the contract to Dena Stahlbau, a German specialist manufacturer, Banedanmark ensures a reliable supply of high-quality milled rail inserts for its track construction and maintenance needs. The price-only evaluation reflects the standardised nature of railway track components, with quality assured through technical specifications. The cross-border award demonstrates the integrated nature of the European railway supply market. As Denmark continues to invest in its rail infrastructure, similar procurements will provide opportunities for railway component manufacturers with competitive pricing and specialist capabilities. Frequently Asked Questions Q: What is Banedanmark? Ans: The Danish railway infrastructure manager, responsible for operating, maintaining, and developing Denmark's rail network. Q: What is the value of the framework? Ans: Up to DKK 80,000,000 (approximately €10.7 million). Q: Who won the contract? Ans: Dena Stahlbau GmbH & Co. KG, a German steel construction company. Q: What are milled rail inserts? Ans: Specialised milled components used in railway track construction and maintenance. Q: What were the evaluation criteria? Ans: Price only. Q: How long is the contract? Ans: 4 years with 2 x 2-year extension options (max 8 years). Q: How many bids were received? Ans: Two bids were received. Q: Is this contract funded by the EU? Ans: No, the procurement is not financed with EU funds. Source: EU Official Journal, Contract Award Notice 572156-2026, OJ S 158/2026, published 18 August 2026. body { font-family: sans-serif; margin: 20px; } table { border-collapse: collapse; width: 100%; margin: 15px 0; } th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; } th { background-color: #f2f2f2; } ul { padding-left: 20px; } h2 { margin-top: 30px; } h3 { margin-top: 20px; }
View Details
Amgros Awards DKK 13.1 Million Metreleptin Framework to Chiesi Pharma
17 Aug 2026
Amgros I/S has awarded a DKK 13.1 million framework agreement for Metreleptin to Chiesi Pharma AB. The single-lot framework covers the supply of the orphan drug for the treatment of leptin deficiency and lipodystrophy to Danish hospital pharmacies, with the contract running from December 2026 to March 2030. Introduction Specialist medicines for rare diseases are essential for patients with specific medical conditions. Amgros, the Danish central purchasing body for pharmaceuticals, has awarded a framework for Metreleptin—an orphan drug used to treat leptin deficiency and lipodystrophy. The framework, valued at up to DKK 13.1 million (approximately €1.76 million), has been awarded to Chiesi Pharma AB. The contract covers three strengths of Metreleptin (3 mg, 5.8 mg, and 11.3 mg) for Danish hospital pharmacies. The contract runs from December 2026 to March 2030, with two 12-month extension options. This procurement ensures that Danish hospitals have access to this essential orphan drug for patients with rare metabolic conditions. Why This Contract Matters Metreleptin is an orphan drug used to treat leptin deficiency and lipodystrophy—rare conditions that require specialist treatment. This framework ensures the supply of this essential medicine to Danish hospital pharmacies. This contract matters because it: Supports rare disease treatment: Ensures access to Metreleptin for patients with lipodystrophy and leptin deficiency Orphan drug: Metreleptin is an orphan drug with a small patient population Significant value: DKK 13.1 million framework Long-term supply: 3+ years with extension options Single supplier: Chiesi Pharma is the sole bidder Price-focused: Price-only evaluation (100%) Swedish supplier: Chiesi Pharma AB is based in Sweden Contract Timeline Contract award notice published: 17 August 2026 (OJ S 157/2026) Previous notice referenced: 307778-2026 Contract concluded: 14 August 2026 Coverage start date: 1 December 2026 Coverage end date: 31 March 2030 Contract Overview Amgros conducted an open procedure for this procurement. The framework covers the supply of Metreleptin for Danish hospital pharmacies, with potential resale to the Faroe Islands and Greenland. Key features include: Single lot: Metreleptin (three strengths) Duration: 1 December 2026 – 31 March 2030 (with 2 x 12-month extension options) Value: DKK 13,100,000 Evaluation: Price only (100%) Framework type: Without reopening of competition Non-exclusive: Hospital pharmacies are not obligated to use the framework Winner: Chiesi Pharma AB Key Contract Details Detail Information Contracting authority Amgros I/S Winning bidder Chiesi Pharma AB Contract subject Metreleptin (orphan drug) – CPV 33600000 Procedure type Open procedure Legal basis EU Directive 2014/24/EU Maximum value (DKK) DKK 13,100,000.00 (approx. €1.76 million) Awarded value (DKK) DKK 7,770,000.00 Contract duration 1 Dec 2026 – 31 Mar 2030 (+ 2 x 12-month options) Bids received 1 EU funding None Covered by GPA Yes Evaluation criteria Price only (100%) Subcontracting No Supplier size SME Project Scope The framework covers the supply of Metreleptin for Danish hospital pharmacies: Products Covered ATC Code: A16AA07 Generic name: Metreleptin Dispensing form: Powder for injection solution Strengths: 3 mg (99 units estimated) 5.8 mg (742 units estimated) 11.3 mg (99 units estimated) Indications Leptin deficiency: Congenital or acquired leptin deficiency Lipodystrophy: Generalised lipodystrophy Orphan drug: Used for rare metabolic conditions Delivery Delivery locations: Amgros warehouse, hospitals, and hospital pharmacies across Denmark Regions covered: All five Danish regions Potential resale: Faroe Islands and Greenland Contract Features Non-exclusive: Hospital pharmacies are not obligated to use the framework No purchase obligation: Hospital pharmacies can source from other suppliers Pre- and post-agreement period options: Flexible ordering About the Contracting Authority Amgros I/S is a Danish joint procurement body (interessentskab) owned by the five Danish regions. Amgros is responsible for purchasing pharmaceuticals and medical equipment for the Danish hospital sector. As a central purchasing body, Amgros negotiates framework agreements that are available to hospital pharmacies across Denmark. About the Winning Company Chiesi Pharma AB is a Swedish pharmaceutical company based in Stockholm, part of the Chiesi Group, an international pharmaceutical company specialising in respiratory, rare disease, and specialist medicines. Chiesi has expertise in orphan drugs and rare disease treatments. The company's winning bid was the only tender received. Procurement Analysis Procedure: An open procedure was used, allowing any interested economic operator to submit a tender. Competition: Only one bid was received, reflecting the specialist nature of orphan drugs like Metreleptin. Evaluation criteria: Price only (100%). This is standard for pharmaceutical procurement where quality is assured through regulatory approvals. Orphan drug market: The limited number of suppliers reflects the small patient population and specialist manufacturing requirements. Single supplier: Chiesi Pharma was the sole bidder. International participation: The winner is a Swedish company, demonstrating cross-border pharmaceutical supply. SME supplier: Chiesi Pharma AB is an SME. Additional Procurement Facts The contract is covered by the WTO's Government Procurement Agreement (GPA). No EU funds were used for this procurement. The procurement was not accelerated. No dynamic purchasing system was used. Framework agreement without reopening of competition. Only one bid was received (from Chiesi Pharma). The bidder is an SME. No subcontracting was declared. Disputes or review requests fall to Klagenævnet for Udbud. Delivery locations include hospitals and hospital pharmacies across all Danish regions. Market & Industry Perspective The market for orphan drugs is characterised by a limited number of suppliers due to the small patient populations and complex manufacturing requirements. Metreleptin is a niche product with only a few suppliers globally. Key trends in this market include: Orphan drug focus: Growing attention to rare disease treatments Limited competition: Orphan drugs often have few suppliers Price focus: Price-only evaluation drives competition where possible Centralised procurement: Amgros centralises procurement for efficiency Cross-border supply: Suppliers from across Europe compete The single-bid outcome reflects the specialist nature of Metreleptin and the limited number of suppliers capable of manufacturing this orphan drug. Economic Significance At DKK 13.1 million, this framework represents a significant procurement for a specialist orphan drug. The contract ensures: Patient access: Patients with lipodystrophy and leptin deficiency can access treatment Supply security: Danish hospital pharmacies have a reliable supply Cost efficiency: Competitive procurement ensures value for money Regional coverage: All five Danish regions are covered Future Procurement Opportunities With the framework now in place, future opportunities include: Contract extensions: Up to 2 x 12-month extension options Re-tender: The framework will be re-tendered after 2030 Other orphan drugs: Similar frameworks for other rare disease medicines Other Amgros tenders: Amgros conducts many pharmaceutical procurements Opportunities for Suppliers While this framework is awarded, future opportunities exist for pharmaceutical companies: Other Amgros tenders: Amgros conducts many other pharmaceutical procurements Other orphan drugs: Similar frameworks for other rare disease medicines Other European countries: Similar frameworks by other central purchasing bodies Re-tender: The framework will be re-tendered in the future What Businesses Should Watch Amgros' future procurement notices for orphan drugs Other European central purchasing bodies' orphan drug tenders Emerging rare disease treatments Changes to Danish pharmaceutical regulations EU orphan drug regulations DenmarkTenders Procurement Intelligence This Metreleptin framework is a significant procurement for a specialist orphan drug. Several features stand out: Scale: DKK 13.1 million for a rare disease medicine Orphan drug: Specialist product with limited supplier base Price focus: Price-only evaluation (100%) Single bidder: Reflects the specialist nature of the product International supplier: Swedish company supplying the Danish market For suppliers, this procurement highlights the importance of: Competitive pricing: Price is the sole criterion (100%) Regulatory compliance: Quality is assured through regulatory approvals European presence: Ability to supply across borders Orphan drug expertise: Specialist manufacturing and distribution capabilities Supplier Takeaways Offer competitive pricing—price is the sole criterion (100%) Ensure regulatory compliance for pharmaceutical products Develop European presence to participate in cross-border tenders Build expertise in orphan drugs and rare disease treatments Monitor Amgros for future pharmaceutical opportunities Consider SME status as an advantage in this market Key Takeaways Amgros awarded a DKK 13.1 million Metreleptin framework to Chiesi Pharma AB Single lot covering 3 strengths of Metreleptin (3 mg, 5.8 mg, 11.3 mg) Orphan drug for lipodystrophy and leptin deficiency Evaluation: Price only (100%) 1 bid received (Chiesi Pharma) Duration: 1 Dec 2026 – 31 Mar 2030 (+ 2 x 12-month options) Swedish supplier (SME) No EU funding used Conclusion This Metreleptin framework represents a significant procurement for an essential orphan drug for Danish hospital pharmacies. By awarding the contract to Chiesi Pharma AB, Amgros ensures that patients with leptin deficiency and lipodystrophy have access to this specialist treatment. The single-bid outcome reflects the limited number of suppliers for orphan drugs, which are complex to manufacture and serve small patient populations. The price-only evaluation (100%) is standard for pharmaceutical procurement, where quality is assured through regulatory approvals. As Amgros continues to conduct pharmaceutical procurements for the Danish hospital sector, further opportunities will arise for suppliers with competitive pricing and specialist capabilities. Frequently Asked Questions Q: What is Amgros? Ans: A Danish joint procurement body (interessentskab) owned by the five Danish regions, responsible for purchasing pharmaceuticals for the hospital sector. Q: What is the value of the framework? Ans: DKK 13,100,000 (approximately €1.76 million). Q: Who won the contract? Ans: Chiesi Pharma AB, a Swedish pharmaceutical company. Q: What is Metreleptin? Ans: An orphan drug used to treat leptin deficiency and lipodystrophy. Q: What were the evaluation criteria? Ans: Price only (100%). Q: How long is the contract? Ans: 1 December 2026 – 31 March 2030 (with 2 x 12-month extension options). Q: How many bids were received? Ans: Only one bid was received. Q: Is this contract funded by the EU? Ans: No, the procurement is not financed with EU funds. Source: EU Official Journal, Contract Award Notice 566842-2026, OJ S 157/2026, published 17 August 2026. body { font-family: sans-serif; margin: 20px; } table { border-collapse: collapse; width: 100%; margin: 15px 0; } th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; } th { background-color: #f2f2f2; } ul { padding-left: 20px; } h2 { margin-top: 30px; } h3 { margin-top: 20px; }
View Details
Energinet Awards €4.08 Million GIS Substation Contract to Hitachi Energy
14 Aug 2026
Energinet Eltransmission A/S has awarded a €4.08 million contract to Hitachi Energy Denmark A/S for the supply of a 145 kV Gas-Insulated Switchgear (GIS) substation for Ølstykke. The contract covers a complete GIS with alternative gas, double busbar configuration, including 2 line-feeder bays, 2 transformer bays, 1 busbar coupler bay, and 2 metering bays. Introduction Reliable and efficient electrical transmission infrastructure is essential for Denmark's energy system. Energinet, the Danish transmission system operator, is investing in substation upgrades to support the country's electricity grid. Energinet has awarded a €4.08 million contract to Hitachi Energy Denmark A/S for the supply of a 145 kV Gas-Insulated Switchgear (GIS) substation for the Ølstykke substation. The contract covers a complete GIS with alternative gas, double busbar configuration, including 2 line-feeder bays, 2 transformer bays, 1 busbar coupler bay, and 2 metering bays. This investment ensures the reliability and capacity of the electricity transmission network in the Nordsjælland region. Why This Contract Matters Gas-insulated switchgear is critical for reliable electricity transmission, providing compact, safe, and maintenance-efficient solutions for substations. This investment supports Denmark's energy infrastructure. This contract matters because it: Supports grid reliability: Upgrades the Ølstykke substation with modern GIS technology Alternative gas: Uses environmentally friendly alternative gas instead of SF6 Significant investment: €4.08 million contract Quality-focused: Quality weighting of 70% (Technical solution 60%, HSE 5%, Cyber Security 5%) Specialist supplier: Hitachi Energy is a global leader in GIS technology Competitive process: Negotiated procedure with two bids received Denmark-based supplier: Hitachi Energy Denmark A/S Contract Timeline Contract award notice published: 14 August 2026 (OJ S 156/2026) Contract concluded: 10 August 2026 Coverage start date: 10 August 2026 Coverage end date: 15 January 2029 Contract Overview Energinet conducted a negotiated procedure with prior publication (competitive with negotiation) for this procurement. The contract covers the supply of a 145 kV GIS substation for the Ølstykke site. Key features include: Single lot: 145 kV GIS substation Duration: 10 August 2026 – 15 January 2029 Value: €4,084,300.00 Evaluation: Quality (70%) and Price (30%) Quality criteria: Technical solution (60%), Health, Safety and Environment (5%), Cyber Security (5%) Winner: Hitachi Energy Denmark A/S Bids: 2 tenders received Key Contract Details Detail Information Contracting authority Energinet Eltransmission A/S Winning bidder Hitachi Energy Denmark A/S Contract subject 145 kV GIS substation (CPV 31000000) Procedure type Negotiated with prior publication / Competitive with negotiation Legal basis EU Directive 2014/25/EU Awarded value (EUR) €4,084,300.00 Contract duration 10 Aug 2026 – 15 Jan 2029 Bids received 2 EU funding None Covered by GPA Yes Evaluation criteria Technical solution (60%), Price (30%), HSE (5%), Cyber Security (5%) Subcontracting No Location Ølstykke, Nordsjælland, Denmark Project Scope The contract covers the supply of a 145 kV Gas-Insulated Switchgear (GIS) substation for the Ølstykke substation. GIS Substation Configuration Type: 3 phase, 145 kV, 50 Hz, Gas-Insulated Switchgear (GIS) Gas: Alternative gas (environmentally friendly alternative to SF6) Busbar: Double busbar configuration Bays: 2 x line-feeder bays 2 x transformer bays 1 x busbar coupler bay 2 x metering bays Delivery: Ready for operation at Energinet's site Installation: In a new building at the Ølstykke site Evaluation Criteria Technical solution (60%): Detailed technical description, maintenance, project-specific methods, testing, documentation Price (30%): Total cost evaluation Health, Safety and Environment (5%): HSE setup, RAMS, risk assessments, method statements Cyber Security (5%): Cyber security solution description, compliance with Energinet's cyber security requirements About the Contracting Authority Energinet Eltransmission A/S is a subsidiary of Energinet, the Danish transmission system operator for electricity. Energinet is responsible for operating and developing Denmark's electricity transmission grid, ensuring reliable and efficient power supply across the country. About the Winning Company Hitachi Energy Denmark A/S is the Danish subsidiary of Hitachi Energy, a global leader in power grids and energy technology. Hitachi Energy is a world-leading provider of gas-insulated switchgear (GIS), transformers, and other transmission and distribution equipment. The company's GIS technology is used in substations worldwide. Hitachi Energy Denmark's winning bid of €4,084,300 was the lowest of two tenders received. Procurement Analysis Procedure: A negotiated procedure with prior publication (competitive with negotiation) was used, reflecting the specialist nature of GIS substation supply. Competition: Two bids were received, representing a competitive field for a specialist high-voltage equipment procurement. Evaluation criteria: Quality (70%) and Price (30%). The heavy weighting on quality reflects the importance of technical performance, reliability, and safety. Quality criteria: Technical solution (60%), HSE (5%), Cyber Security (5%). Value for money: The winning bid (€4.08 million) was significantly below the highest bid (€4.73 million), a saving of approximately 14%. Alternative gas: The use of alternative gas instead of SF6 reflects environmental considerations. No subcontracting: Hitachi Energy will deliver without subcontracting. Additional Procurement Facts The contract is covered by the WTO's Government Procurement Agreement (GPA). No EU funds were used for this procurement. The procurement was not accelerated. No dynamic purchasing system was used. No framework agreement was used—this is a direct supply contract. Two bids were received. No subcontracting was declared by the winner. Disputes or review requests fall to Klagenævnet for Udbud. The contract includes alternative gas (non-SF6) GIS technology. Market & Industry Perspective The market for high-voltage GIS substations is dominated by a few global players, including Hitachi Energy, Siemens Energy, and GE Grid Solutions. These systems are highly specialised and represent significant investments for grid operators. Key trends in this market include: Alternative gases: Phasing out SF6 in favour of environmentally friendly alternatives Grid modernisation: Investment in transmission infrastructure Cyber security: Increasing focus on cyber security for critical infrastructure Compact design: GIS systems offer space-saving solutions Reliability: High reliability and low maintenance requirements Economic Significance At €4.08 million, this contract represents a significant investment in Denmark's electricity transmission infrastructure. The GIS substation will: Enhance grid reliability: Modernise the Ølstykke substation Support renewable energy: Enable integration of renewable energy sources Reduce environmental impact: Use alternative gas instead of SF6 Support Danish energy transition: Contribute to Denmark's climate goals Future Procurement Opportunities With the contract now awarded, future opportunities include: Other substations: Similar procurements for other Energinet substations Maintenance contracts: Ongoing maintenance of GIS equipment Grid expansion: Additional transmission infrastructure projects Other European TSOs: Similar procurements by other transmission system operators Opportunities for Suppliers While this contract is awarded, future opportunities exist for high-voltage equipment suppliers: Other substations: Similar procurements for other Energinet substations Other TSOs: Similar procurements by other European transmission system operators Alternative gas technology: Growing demand for non-SF6 GIS Maintenance: Ongoing maintenance and service contracts What Businesses Should Watch Energinet's future procurement notices for substation equipment Other European TSOs' GIS procurement notices Alternative gas technology developments Cyber security requirements for critical infrastructure EU energy and climate policy developments DenmarkTenders Procurement Intelligence This GIS substation procurement is a significant contract for Energinet's transmission infrastructure. Several features stand out: Scale: €4.08 million for a complete GIS substation Quality focus: Quality weighting of 70% Alternative gas: Use of environmentally friendly gas instead of SF6 Cyber security: 5% weighting for cyber security requirements Specialist supplier: Hitachi Energy is a global market leader For suppliers, this procurement highlights the importance of: Technical quality: Demonstrating technical excellence (60% of evaluation) Competitive pricing: Price accounts for 30% of evaluation HSE and cyber security: 5% each for HSE and cyber security Alternative gas: Offering non-SF6 solutions Global presence: Being a recognised global supplier Supplier Takeaways Demonstrate technical quality—60% of evaluation is quality-based Offer competitive pricing—price accounts for 30% Show strong HSE and cyber security credentials Offer alternative gas (non-SF6) solutions Monitor Energinet and other TSOs for future GIS procurements Build relationships with transmission system operators Key Takeaways Energinet awarded a €4.08 million GIS substation contract to Hitachi Energy Project: 145 kV GIS substation for Ølstykke with alternative gas Scope: 2 line-feeder bays, 2 transformer bays, 1 busbar coupler bay, 2 metering bays Evaluation: Technical solution (60%), Price (30%), HSE (5%), Cyber Security (5%) 2 bids received; winning bid 14% below highest bid Duration: 10 August 2026 – 15 January 2029 No subcontracting Alternative gas (non-SF6) GIS technology Conclusion This GIS substation contract represents a significant investment in Denmark's electricity transmission infrastructure. By awarding the contract to Hitachi Energy Denmark, Energinet ensures that the Ølstykke substation will be equipped with state-of-the-art, environmentally friendly GIS technology. The 70% quality weighting reflects the importance of technical performance, reliability, and safety in high-voltage equipment. The inclusion of alternative gas (non-SF6) technology aligns with environmental goals, while the 5% weighting for cyber security reflects the growing importance of protecting critical infrastructure. As Denmark continues to develop its energy infrastructure, similar procurements will provide opportunities for suppliers with strong technical capabilities and environmental credentials. Frequently Asked Questions Q: What is Energinet? Ans: The Danish transmission system operator for electricity, responsible for operating and developing Denmark's electricity transmission grid. Q: What is the value of the contract? Ans: €4,084,300.00. Q: Who won the contract? Ans: Hitachi Energy Denmark A/S. Q: What is being procured? Ans: A 145 kV Gas-Insulated Switchgear (GIS) substation for Ølstykke. Q: What is alternative gas? Ans: An environmentally friendly alternative to SF6 (sulphur hexafluoride), a potent greenhouse gas traditionally used in GIS. Q: What were the evaluation criteria? Ans: Technical solution (60%), Price (30%), HSE (5%), Cyber Security (5%). Q: How many bids were received? Ans: Two bids were received. Q: Is this contract funded by the EU? Ans: No, the procurement is not financed with EU funds. Source: EU Official Journal, Contract Award Notice 564575-2026, OJ S 156/2026, published 14 August 2026. body { font-family: sans-serif; margin: 20px; } table { border-collapse: collapse; width: 100%; margin: 15px 0; } th, td { border: 1px solid #ddd; padding: 8px; text-align: left; vertical-align: top; } th { background-color: #f2f2f2; } ul { padding-left: 20px; } h2 { margin-top: 30px; } h3 { margin-top: 20px; }
View Details